HUP0401182A2 - Vakcinakészítmény, amely legalább két valenciát tartalmaz, az egyik adjuvánsozott, a másik pedig nem - Google Patents

Vakcinakészítmény, amely legalább két valenciát tartalmaz, az egyik adjuvánsozott, a másik pedig nem

Info

Publication number
HUP0401182A2
HUP0401182A2 HU0401182A HUP0401182A HUP0401182A2 HU P0401182 A2 HUP0401182 A2 HU P0401182A2 HU 0401182 A HU0401182 A HU 0401182A HU P0401182 A HUP0401182 A HU P0401182A HU P0401182 A2 HUP0401182 A2 HU P0401182A2
Authority
HU
Hungary
Prior art keywords
valence
valences
adjuvant
enhanced
vaccine composition
Prior art date
Application number
HU0401182A
Other languages
English (en)
Inventor
Alain Francon
Original Assignee
Aventis Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8866367&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0401182(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pasteur filed Critical Aventis Pasteur
Publication of HUP0401182A2 publication Critical patent/HUP0401182A2/hu
Publication of HUP0401182A3 publication Critical patent/HUP0401182A3/hu
Publication of HU228216B1 publication Critical patent/HU228216B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

A találmány tárgya két valenciát tartalmazó vakcinakészítmény; (i) egyelső, alumínium-hidroxiddal adjuvánsozott valenciát, és (ii) egymásodik valenciát, amely egy vagy több O-acetil-csoportot tartalmazóbakteriális burokpoliszaccharidot tartalmaz, és amely nincsadszorbeálódva az alumínium-oxidra egy védő vegyület jelenléte miatt,amely lehet foszfát, citrát vagy karbonát, amely megakadályozza azadszorpciót. Az első valencia bármilyen vakcina valencia lehet. Egyelőnyös megvalósítási mód szerint a vakcinakészítmény (i) alumínium-hidroxidra adszorbeált Hepatitisz-A valenciát, és (ii) a Salmonellatyphi burok Vipoliszaccharidja által alkotott tífusz valenciáttartalmazza. Ó
HU0401182A 2001-08-08 2002-07-31 Vaccine composition comprising at least two valences, one enhanced with adjuvant and not the other HU228216B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0110573A FR2828406B1 (fr) 2001-08-08 2001-08-08 Composition vaccinale bivalente havi
PCT/FR2002/002770 WO2003013600A1 (fr) 2001-08-08 2002-07-31 Composition vaccinale comprenant au moins deux valances, l'une adjuvantee, l'autre pas

Publications (3)

Publication Number Publication Date
HUP0401182A2 true HUP0401182A2 (hu) 2004-09-28
HUP0401182A3 HUP0401182A3 (en) 2004-10-28
HU228216B1 HU228216B1 (en) 2013-02-28

Family

ID=8866367

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0401182A HU228216B1 (en) 2001-08-08 2002-07-31 Vaccine composition comprising at least two valences, one enhanced with adjuvant and not the other

Country Status (22)

Country Link
US (1) US7404960B2 (hu)
EP (1) EP1416958B2 (hu)
JP (1) JP4221291B2 (hu)
KR (1) KR100881703B1 (hu)
CN (1) CN1282486C (hu)
AT (1) ATE357929T1 (hu)
AU (1) AU2002342949B2 (hu)
BR (1) BRPI0211151B8 (hu)
CA (1) CA2455406C (hu)
CY (1) CY1107619T1 (hu)
DE (1) DE60219177T3 (hu)
DK (1) DK1416958T4 (hu)
ES (1) ES2284940T5 (hu)
FR (1) FR2828406B1 (hu)
HU (1) HU228216B1 (hu)
IL (2) IL159519A0 (hu)
MX (1) MXPA04001125A (hu)
NZ (1) NZ530727A (hu)
PL (1) PL215134B1 (hu)
PT (1) PT1416958E (hu)
WO (1) WO2003013600A1 (hu)
ZA (1) ZA200400022B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2464522C (en) 2004-04-15 2011-11-15 Eng-Hong Lee Soft gel delivery system for treating poultry
ES2387582T3 (es) * 2006-09-07 2012-09-26 Glaxosmithkline Biologicals S.A. Vacuna de combinación con cantidades reducidas del antígeno del virus de la polio
KR101101901B1 (ko) * 2009-01-30 2012-01-02 주식회사 리노 주방용 선반
AU2010227219B2 (en) 2009-03-24 2014-02-27 Glaxosmithkline Biologicals S.A. Adjuvanting meningococcal factor H binding protein
CN102526724B (zh) * 2011-01-14 2015-07-22 四川大学 氢氧化铝凝胶-多糖复合免疫佐剂及其制备方法和用途
FR2985663B1 (fr) 2012-01-17 2015-03-27 Sanofi Pasteur Procede de formulation d'un vaccin contenant au moins deux antigenes susceptibles de s'adsorber sur de l'oxy hydroxyde d'aluminium

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2734484B1 (fr) * 1995-05-24 1997-06-27 Pasteur Merieux Serums Vacc Composition vaccinale liquide et procede de fabrication
GB9806456D0 (en) * 1998-03-25 1998-05-27 Smithkline Beecham Biolog Vaccine composition
EP1107787B1 (en) * 1998-08-28 2003-05-14 GlaxoSmithKline Biologicals S.A. Salmonella typhi vaccine compositions
US6585973B1 (en) * 1998-10-29 2003-07-01 Henry M. Jackson Foundation For The Advancement Of Military Medicine Method for preparing solid phase conjugated vaccine
GB9909077D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Biolog Novel compositions

Also Published As

Publication number Publication date
CN1282486C (zh) 2006-11-01
KR100881703B1 (ko) 2009-02-06
ES2284940T5 (es) 2012-07-02
BRPI0211151B1 (pt) 2019-07-09
US20040170648A1 (en) 2004-09-02
JP2005501081A (ja) 2005-01-13
PL215134B1 (pl) 2013-10-31
PL367904A1 (en) 2005-03-07
ATE357929T1 (de) 2007-04-15
IL159519A0 (en) 2004-06-01
EP1416958B1 (fr) 2007-03-28
DK1416958T4 (da) 2012-07-09
DE60219177T3 (de) 2012-08-30
MXPA04001125A (es) 2004-05-20
EP1416958B2 (fr) 2012-03-14
HU228216B1 (en) 2013-02-28
US7404960B2 (en) 2008-07-29
NZ530727A (en) 2004-06-25
FR2828406A1 (fr) 2003-02-14
CA2455406A1 (en) 2003-02-20
DE60219177D1 (de) 2007-05-10
ZA200400022B (en) 2006-05-31
EP1416958A1 (fr) 2004-05-12
BR0211151A (pt) 2004-08-10
HUP0401182A3 (en) 2004-10-28
PT1416958E (pt) 2007-05-31
IL159519A (en) 2010-11-30
CY1107619T1 (el) 2013-04-18
ES2284940T3 (es) 2007-11-16
FR2828406B1 (fr) 2005-06-24
DK1416958T3 (da) 2007-07-30
JP4221291B2 (ja) 2009-02-12
CN1541108A (zh) 2004-10-27
CA2455406C (en) 2012-03-13
AU2002342949B2 (en) 2007-07-05
KR20040043182A (ko) 2004-05-22
WO2003013600A1 (fr) 2003-02-20
DE60219177T2 (de) 2008-01-24
BRPI0211151B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
HUP0101047A1 (hu) Kombinált vakcinakészítmények
ATE309821T1 (de) Influenzavirus-impfstoffzusammensetzung
DK0528859T3 (da) Oral vaccine, som omfatter antigen knyttet til overfladen af røde blodlegemer
DK1401489T4 (da) Solubilisering af kapselpolysaccharid
ATE315404T1 (de) Influenzavirus-impfstoffzusammensetzung
HUP0203091A1 (hu) Adjuvánsrendszerek és vakcinák
MXPA01007760A (es) Compuesto adyuvante inmunologico.
HUP0500238A2 (hu) Interleukin-12 alkalmazása állatgyógyászati vakcina adjuvánsként
HUP0401182A2 (hu) Vakcinakészítmény, amely legalább két valenciát tartalmaz, az egyik adjuvánsozott, a másik pedig nem
TW340873B (en) Chicken anaemia agent vaccine
DE60218662D1 (de) Heterologer schutz, induziert durch immunisierung mit der invaplex-vakzine
DE60115051D1 (de) Immunologische adjuvans verbindungen
HU9801705D0 (en) Streptococcus equi vaccine
CA2222482A1 (en) Non-virulent mycoplasma synoviae and vaccine thereof
NZ510130A (en) Chicken anaemia viruses of low pathogenicity
PL348550A1 (en) Ibdv mutant, vaccine containing it for protecting poultry against a disease caused by ibdv and method of protecting poultry against such disease
ES2193742T3 (es) Composiciones de vacuna que contienen salmonella typhi.
WO2002024147A3 (en) Avian pneumovirus vaccine
MX9701445A (es) Eterotoxina mutante eficaz como adyuvante oral no toxico.